»Go to related Japanese page in JPubb

Loading

Press Releases by "Taiho Pharmaceutical Co., Ltd."


You may also like to check companies from Taiho Pharmaceutical Co., Ltd.'s related industry or location as follows: Pharmaceuticals, Tokyo

1 - 33 of 33 for your search
Announcement; Launch of 5-HT3 Receptor Antagonist Aloxi® I.V. infusion bag 0.75mg
[ Pharmaceuticals | 2012-11-30]
ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis, Intra-abdominal Abscess, Cholecystitis, and Cholangitis
[ Pharmaceuticals | 2012-09-28]
Clinical Trial (JASPAC 01) of TS-1 for Resected Pancreatic Cancer
[ Pharmaceuticals | 2012-09-18]
Results of a Phase II Clinical Trial for the Novel Antitumor Agent TAS-102 Posted on the Electronic Edition of The Lancet Oncology
[ Pharmaceuticals | 2012-08-28]
Taiho and Faes Farma (Spain) Enter into a License Agreement on Anti-Allergy Agent
[ Pharmaceuticals | 2012-07-24]
Launch of Histamine H2 Receptor Antagonist PROTECADIN® OD Tablets (Orally Disintegrating Tablet)
[ Pharmaceuticals | 2012-06-22]
Phase III Clinical Trial (CATS TRIAL) for Non-small-cell Lung Cancer Non-inferiority of TS-1 + Cisplatin Treatment Verified Presented to the American Society of Clinical Oncology (ASCO)
[ Pharmaceuticals | 2012-06-06]
Taiho Pharmaceutical Announces the Start of a Global Phase III Clinical Trial in Metastatic Colorectal Cancer with the Novel Antitumor Agent TAS-102
[ Pharmaceuticals | 2012-05-31]
Anti-Cancer Drug Teysuno® has been launched in the United Kingdom.
[ Pharmaceuticals | 2012-04-11]
Taiho Pharmaceutical’s Anticancer Agent TS-1 Approved for Market in Hong Kong
[ Pharmaceuticals | 2012-04-11]
Anti-Cancer Drug TeysunoTM has been launched in Sweden, Denmark, Norway and Finland
[ Pharmaceuticals | 2012-03-21]
Taiho Pharmaceutical Co., Ltd. and Nordic Group BV have launched Anti-Cancer Drug TeysunoTM in Sweden, Denmark, Norway and Finland
[ Pharmaceuticals | 2012-03-21]
Taiho Pharmaceutical’s Anticancer Agent TS-1 Approved for Market in Thailand
[ Pharmaceuticals | 2012-03-21]
Licensing Agreement Cancelled for NST-141 Agent for Pruritus in Atopic Dermatitis
[ Pharmaceuticals | 2012-03-09]
ABRAXANE® I.V. Infusion 100mg Application Submitted for Approval of Additional Indications in Japan
[ Pharmaceuticals | 2012-03-01]
Taiho Pharmaceutical to Launch a New Anti-tumor Agent, ZOLINZA® capsules 100mg, on September 14
[ Pharmaceuticals | 2011-09-12]
Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102 - Positive Results of Overall Survival in Patients with Colorectal Cancer Refractory to Standard Chemotherapy -
[ Pharmaceuticals | 2011-07-22]
Presentation to the American Society of Clinical Oncology of results of final analysis of a clinical study in patients with unresectable colorectal cancer (FIRIS study)
[ Pharmaceuticals | 2011-06-06]
Announcement of License Agreement on a New Antiemetic Combination Agent
[ Pharmaceuticals | 2011-04-13]
TEYSUNO™ (S-1) RECEIVES EUROPEAN MARKETING AUTHORIZATION AS FIRST-LINE THERAPY FOR ADVANCED GASTRIC CANCER
[ Pharmaceuticals | 2011-03-15]
Taiho Pharmaceutical Announces Results of Gemcitabine and TS-1 Trial (GEST) on Advanced Pancreatic Cancer
[ Pharmaceuticals | 2011-01-26]
TEYSUNO™ (S-1) RECEIVES CHMP POSITIVE OPINION FOR APPROVAL AS FIRST-LINE THERAPY FOR ADVANCED GASTRIC CANCER
[ Pharmaceuticals | 2010-12-20]
Regarding the results of a five-year follow-up study in the Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
[ Pharmaceuticals | 2010-10-12]
Antineoplastic ABRAXANE® to be Launched Friday, September 24
[ Pharmaceuticals | 2010-09-17]
Abraxane® Approved for Marketing in Japan for Breast Cancer
[ Pharmaceuticals | 2010-07-23]
5-HT3 Receptor Antagonist, Aloxi® on April 22
[ Pharmaceuticals | 2010-04-21]
Helsinn Group and Taiho Pharmaceutical Announce Approval of OncologyPalonosetron in Japan,,the World’s Second Largest Pharmaceutical Market
[ Pharmaceuticals | 2010-01-20]
Taiho to Buy Tsukuba Research Institute from Banyu
[ Pharmaceuticals | 2009-08-03]
Taiho Pharmaceutical’s Anticancer Agent TS-1 Approved for Market in Singapore
[ Pharmaceuticals | 2009-07-21]
Taiho Pharmaceutical and PharmaMar of Spain Sign License Agreement on Antitumor Agent Yondelis® (Trabectedin)
[ Pharmaceuticals | 2009-03-31]
Taiho Pharmaceutical and Toray Industries Now Working Together to Develop a ß3-Adrenoceptor Agonist
[ Pharmaceuticals | 2009-03-11]
License agreement with Sanofi-Aventis on TS-1 is terminated
[ Pharmaceuticals | 2008-07-18]
Results of a randomized comparative phase 3 study of S-1 in advanced/recurrent gastric cancer become available
[ Pharmaceuticals | 2008-07-18]

You may also like to check companies from Taiho Pharmaceutical Co., Ltd.'s related industry or location as follows: Pharmaceuticals, Tokyo

Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Latest Releases: Taiho Pharmaceutical Co., Ltd.
Announcement; Launch of 5-HT3 Receptor Antagonist Aloxi® I.V. infusion bag 0.75mg
2012/11/30
ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis, Intra-abdominal Abscess, Cholecystitis, and Cholangitis
2012/09/28
Clinical Trial (JASPAC 01) of TS-1 for Resected Pancreatic Cancer
2012/09/18
Results of a Phase II Clinical Trial for the Novel Antitumor Agent TAS-102 Posted on the Electronic Edition of The Lancet Oncology
2012/08/28
Taiho and Faes Farma (Spain) Enter into a License Agreement on Anti-Allergy Agent
2012/07/24
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1 | TSE2 | Mothers

OSE (Osaka) All | OSE1 | OSE2 | JASDAQ Standard | JASDAQ Growth

NSE (Nagoya) All | NSE1 | NSE2 | Centrex | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.